Jung et al. [17] also claimed that some epigenetic alterations (for example, methylation of the SEPT9, SHOX2, ALX4, and VIM) were reliable biomarkers for diagnosing CRC. This evidence concerns the gene SEPTIN9 and colorectal carcinoma.